358 related articles for article (PubMed ID: 11391482)
1. Etiological point mutations in the hereditary multiple exostoses gene EXT1: a functional analysis of heparan sulfate polymerase activity.
Cheung PK; McCormick C; Crawford BE; Esko JD; Tufaro F; Duncan G
Am J Hum Genet; 2001 Jul; 69(1):55-66. PubMed ID: 11391482
[TBL] [Abstract][Full Text] [Related]
2. Hereditary multiple exostoses and heparan sulfate polymerization.
Zak BM; Crawford BE; Esko JD
Biochim Biophys Acta; 2002 Dec; 1573(3):346-55. PubMed ID: 12417417
[TBL] [Abstract][Full Text] [Related]
3. The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate.
McCormick C; Duncan G; Goutsos KT; Tufaro F
Proc Natl Acad Sci U S A; 2000 Jan; 97(2):668-73. PubMed ID: 10639137
[TBL] [Abstract][Full Text] [Related]
4. Haploinsufficiency of EXT1 and Heparan Sulphate Deficiency Associated with Hereditary Multiple Exostoses in a Pakistani Family.
Ajmal M; Muhammad H; Nasir M; Shoaib M; Malik SA; Ullah I
Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676722
[No Abstract] [Full Text] [Related]
5. Location of the glucuronosyltransferase domain in the heparan sulfate copolymerase EXT1 by analysis of Chinese hamster ovary cell mutants.
Wei G; Bai X; Gabb MM; Bame KJ; Koshy TI; Spear PG; Esko JD
J Biol Chem; 2000 Sep; 275(36):27733-40. PubMed ID: 10864928
[TBL] [Abstract][Full Text] [Related]
6. Assessing the general population frequency of rare coding variants in the EXT1 and EXT2 genes previously implicated in hereditary multiple exostoses.
Cousminer DL; Arkader A; Voight BF; Pacifici M; Grant SFA
Bone; 2016 Nov; 92():196-200. PubMed ID: 27616605
[TBL] [Abstract][Full Text] [Related]
7. Contribution of EXT1, EXT2, and EXTL3 to heparan sulfate chain elongation.
Busse M; Feta A; Presto J; Wilén M; Grønning M; Kjellén L; Kusche-Gullberg M
J Biol Chem; 2007 Nov; 282(45):32802-10. PubMed ID: 17761672
[TBL] [Abstract][Full Text] [Related]
8. Biosynthesis of heparan sulfate in EXT1-deficient cells.
Okada M; Nadanaka S; Shoji N; Tamura J; Kitagawa H
Biochem J; 2010 May; 428(3):463-71. PubMed ID: 20377530
[TBL] [Abstract][Full Text] [Related]
9. Three novel EXT1 and EXT2 gene mutations in Taiwanese patients with multiple exostoses.
Chen WC; Chi CH; Chuang CC; Jou IM
J Formos Med Assoc; 2006 May; 105(5):434-7. PubMed ID: 16638657
[TBL] [Abstract][Full Text] [Related]
10. Association of EXT1 and EXT2, hereditary multiple exostoses gene products, in Golgi apparatus.
Kobayashi S; Morimoto K; Shimizu T; Takahashi M; Kurosawa H; Shirasawa T
Biochem Biophys Res Commun; 2000 Feb; 268(3):860-7. PubMed ID: 10679296
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the EXT1 and EXT2 genes in hereditary multiple exostoses.
Wuyts W; Van Hul W; De Boulle K; Hendrickx J; Bakker E; Vanhoenacker F; Mollica F; Lüdecke HJ; Sayli BS; Pazzaglia UE; Mortier G; Hamel B; Conrad EU; Matsushita M; Raskind WH; Willems PJ
Am J Hum Genet; 1998 Feb; 62(2):346-54. PubMed ID: 9463333
[TBL] [Abstract][Full Text] [Related]
12. Mutation screening of the EXT1 and EXT2 genes in patients with hereditary multiple exostoses.
Philippe C; Porter DE; Emerton ME; Wells DE; Simpson AH; Monaco AP
Am J Hum Genet; 1997 Sep; 61(3):520-8. PubMed ID: 9326317
[TBL] [Abstract][Full Text] [Related]
13. Identification of four novel EXT1 and EXT2 mutations in five Chinese pedigrees with hereditary multiple exostoses.
Li Y; Wang D; Wang W; Wang J; Li H; Wang J; Wang X; Fu Q
Genet Test Mol Biomarkers; 2009 Dec; 13(6):825-30. PubMed ID: 19839753
[TBL] [Abstract][Full Text] [Related]
14. Identification of Novel Mutations in the
Tong Y; Zhang Y; Luo J; Hong Z; Chen X; Bi Q
Genet Test Mol Biomarkers; 2021 Feb; 25(2):145-151. PubMed ID: 33596140
[No Abstract] [Full Text] [Related]
15. The pathogenic roles of heparan sulfate deficiency in hereditary multiple exostoses.
Pacifici M
Matrix Biol; 2018 Oct; 71-72():28-39. PubMed ID: 29277722
[TBL] [Abstract][Full Text] [Related]
16. Loss of function in heparan sulfate elongation genes EXT1 and EXT 2 results in improved nitric oxide bioavailability and endothelial function.
Mooij HL; Cabrales P; Bernelot Moens SJ; Xu D; Udayappan SD; Tsai AG; van der Sande MA; de Groot E; Intaglietta M; Kastelein JJ; Dallinga-Thie GM; Esko JD; Stroes ES; Nieuwdorp M
J Am Heart Assoc; 2014 Dec; 3(6):e001274. PubMed ID: 25468659
[TBL] [Abstract][Full Text] [Related]
17. Mutation analysis of hereditary multiple exostoses in the Chinese.
Xu L; Xia J; Jiang H; Zhou J; Li H; Wang D; Pan Q; Long Z; Fan C; Deng HX
Hum Genet; 1999; 105(1-2):45-50. PubMed ID: 10480354
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2 genes.
Wuyts W; Van Hul W
Hum Mutat; 2000; 15(3):220-7. PubMed ID: 10679937
[TBL] [Abstract][Full Text] [Related]
19. Mutation frequencies of EXT1 and EXT2 in 43 Japanese families with hereditary multiple exostoses.
Seki H; Kubota T; Ikegawa S; Haga N; Fujioka F; Ohzeki S; Wakui K; Yoshikawa H; Takaoka K; Fukushima Y
Am J Med Genet; 2001 Feb; 99(1):59-62. PubMed ID: 11170095
[TBL] [Abstract][Full Text] [Related]
20. Transgenic expression of the EXT2 gene in developing chondrocytes enhances the synthesis of heparan sulfate and bone formation in mice.
Morimoto K; Shimizu T; Furukawa K; Morio H; Kurosawa H; Shirasawa T
Biochem Biophys Res Commun; 2002 Apr; 292(4):999-1009. PubMed ID: 11944914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
